Cabinet Regulation No. 327 regarding restrictions on the use of drugs for animals

Disclaimer: The English language text below is provided by the Translation and Terminology Centre for information only; it confers no rights and imposes no obligations separate from those conferred or imposed by the legislation formally adopted and published. Only the latter is authentic. The original Latvian text uses masculine pronouns in the singular. The Translation and Terminology Centre uses the principle of gender-neutral language in its English translations. In addition, gender-specific Latvian nouns have been translated as gender-neutral terms, e.g. chairperson. Translation © 2001 Tulkošanas un terminoloģijas centrs (Translation and Terminology Centre) Republic of Latvia Cabinet Regulation No. 327 Adopted 19 September 2000 Regulations Regarding Restrictions on the Use of Drugs for Animals Issued pursuant to Section 5, Clause 11 of the Pharmacy Law 1. These Regulations determine restrictions on the use of drugs for animals. 2. Compliance with these Regulations shall be monitored by the State Veterinary Service. 3. For animals of all species, regardless of the method of administering and the dose of drugs, it is prohibited to use drugs containing: 3.1. stylbene; 3.2. stylbene derivatives, salts or esters thereof; or 3.3. thyreostatic substances. 4. For animals of all species, from which food products of animal origin are obtained (hereinafter – productive animals), as well as for sport animals, it is prohibited to use drugs containing estrogenic, androgenic or gestogenic substances, except in cases provided for in Paragraphs 13 and 15 of these Regulations. 5. For productive animals of all species, regardless of the method of administering and the dose of drugs, it is prohibited to use drugs containing: 5.1. Aristolochia spp.; 5.2. dapson; 5.3. dimetridazol; 5.4. chloramphenicol (levomycetin); 5.5. chloroform; 5.6. chlorpromazin; 5.7. colchicin; 5.8. metronidazol; 5.9. nitrofurans, including furazolidon; 5.10. ronidazol; or 5.11. β-agonists, except in cases provided for in Paragraphs 14 and 15 of these Regulations. 6. For animals of all species, from which milk is obtained for human consumption, it is prohibited to use drugs containing: 6.1. bituminous sulphonate, its ammonium and sodium salts; 6.2. black snake root (Cimifuga racemosa); 6.3. methylprednisolon; 6.4. rue (Ruta graveolens); or 6.5. trichlormetiazid. 7. For cows, regardless of the method of administering and the dose of drugs, it is prohibited to use drugs containing cow somatotropin. 8. For cows, from which milk is obtained for human consumption, it is prohibited to use drugs containing: 8.1. apramycin; Translation © 2001 Tulkošanas un terminoloģijas centrs (Translation and Terminology Centre) 2 2 8.2. bromhexine; 8.3. butaphosphane; 8.4. danofloxacin; 8.5. deltamethrin; 8.6. difloxacin; 8.7. doxycycline; 8.8. doramectin; 8.9. flumequine; 8.10. caprofen; 8.11. xylazin hydrochloride; 8.12. methamizol; 8.13. rapfoxanide; or 8.14. triclabensdazole. 9. For sheep, from which milk is obtained for human consumption, it is prohibited to use drugs containing: 9.1. apramycin; 9.2. cyromazine; 9.3. deltamethrin; 9.4. dicyclanil; 9.5. doramectin; 9.6. enrofloxacine; 9.7. flumequine; 9.8. mebendazole; 9.9. propetamphos; 9.10. rapfoxanide; 9.11. spectinomycin; or 9.12. triclabendazole. 10. For goats, from which milk is obtained for human consumption, it is prohibited to use drugs containing mebendazole: 11. For mares, from which milk is obtained for human consumption, it is prohibited to use drugs containing: 11.1. xylazin hydrochloride; 11.2. mebendazole; or 11.3. methamizol. 12. For poultry, from which eggs are obtained for human consumption, it is prohibited to use drugs containing: 12.1. apramycin; 12.2. bromhexine; 12.3. danofloxacin; 12.4. doxycycline; 12.5. flumequine; 12.6. florfenicol; 12.7. thiamphenicol; 12.8. tilmicosin; 12.9. tilosin; 12.10. toltrazuril; or 12.11. trimethoprim. 13. The use of drugs containing hormones with estrogenic, gestogenic or androgenic effect is permitted for farm animals only in the following cases: 13.1. for reproductive purposes – to synchronise oestrus and, in cases of embryo transplantation, to prepare donors and recipients – on the condition that the necessity to use such drugs is determined, and the drugs are administered, by a practising veterinarian; Translation © 2001 Tulkošanas un terminoloģijas centrs (Translation and Terminology Centre) 3 3 13.2. for breeding fish – drugs containing hormones with androgenic effect, at the age of one to three months for the purpose of gender inversion; and 13.3. estradiol 17 ß, testosterone, progesterone and derivatives thereof – only by injection or as vaginal inserts or spirals (in case of ovary dysfunction), if the necessity to use such drugs is determined, and the drugs are administered, by a practising veterinarian. 14. It is permitted to use β-agonists (for example, clenbuterol, salbutamol, terbutalin, isoxuprine) when rendering assistance to cows, as well as to other productive animals, during parturition if the time period for excretion of such drugs from the organism of the animal does not exceed 28 days after termination of treatment and if the necessity to use such drugs is determined, and the drugs are administered, by a practising veterinarian. 15. It is permitted to use drugs containing allyltrenbolon and β-agonists for equine animals and for domestic (pet) animals if the necessity to use such drugs is determined, and the drugs are administered, by a practising veterinarian. 16. The drugs referred to in Paragraphs 13, 14 and 15 of these Regulations may be used only for animals that are registered and marked in accordance with the procedures set out in regulatory enactments and which can be identified at the moment of administering the drugs. 17. A practising veterinarian, after administering drugs referred to in Paragraphs 13, 14 and 15, shall perform the following: 17.1. for productive animals and sport animals – register the use of drugs in accordance with the procedures set out in regulatory enactments, indicating the name of the drugs, the purpose of the use of such, the date of use, and the animal to which the drugs have been administered (identification number of the animal); 17.2. for productive animals – inform the owner of the animal in writing regarding restrictions or a prohibition in respect of utilisation of products of animal origin for human consumption; and 17.3. for equine animals – if such are transported for breeding or to exhibitions, and if the animals are moved before the time period for excretion of the relevant drugs from the organism has expired, an entry shall be made in the veterinary certificate or the veterinary (health) certificate regarding the use of such drugs as contain β-agonists or allyltrenbolon, indicating the purpose and the date of use. 18. These Regulations shall come into force on 1 November 2000. Prime Minister A. Bērziņš Minister for Agriculture A. Slakteris